The Medomics SARS-CoV-2 Antigen Rapid Test (Nasal Swab) is a rapid test for the qualitative detection of SARS-CoV-2 Nucleocapsid Protein antigens present in nasal swab specimen.
Description
Documents
Cost effective rapid test kit
Medomics Rapid Antigen Test Kits Nasal Swap, ARTG# 380739
For self-testing in vitro diagnostic use.
Intended Use:
The Medomics SARS-CoV-2 Antigen Rapid Test (Nasal Swab) is a single-use test kit intended to detect the SARS-CoV-2 that causes COVID-19 with self-collected nasal swab specimen. The test is intended for use in symptomatic individuals meeting the case definition for COVID-19 within the first 7 days of symptom onset, and to test individuals without symptoms suspected of COVID-19 due to contact with a confirmed COVID-19 case or probable cases and to at-risk health workers.
Results are for the detection of SARS-CoV-2 Nucleocapsid protein Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
The Medomics Antigen Rapid Test (Nasal Swab) obtains a preliminary result only, an aid diagnosis of COVID-19, for the final confirmation should be based on clinical diagnostic results according to local state or territory guidelines.
The Medomics SARS-CoV-2 Antigen Rapid Test (Nasal Swab) is intended to be used by laypersons as a self-test for home and workplace (in offices, for sporting events, airports, schools, etc.).
To contact Biotech Medical Supplies about Medomics Covid-19 Rapid Antigen Test (Nasal Swab) $1.2 | 5 Pack | TGA Approved use Get a quote.
Medomics Rapid Antigen Test Kits Nasal Swap, ARTG# 380739
For self-testing in vitro diagnostic use.
Intended Use:
The Medomics SARS-CoV-2 Antigen Rapid Test (Nasal Swab) is a single-use test kit intended to detect the SARS-CoV-2 that causes COVID-19 with self-collected nasal swab specimen. The test is intended for use in symptomatic individuals meeting the case definition for COVID-19 within the first 7 days of symptom onset, and to test individuals without symptoms suspected of COVID-19 due to contact with a confirmed COVID-19 case or probable cases and to at-risk health workers.
Results are for the detection of SARS-CoV-2 Nucleocapsid protein Antigens. An antigen is generally detectable in upper respiratory specimens during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
The Medomics Antigen Rapid Test (Nasal Swab) obtains a preliminary result only, an aid diagnosis of COVID-19, for the final confirmation should be based on clinical diagnostic results according to local state or territory guidelines.
The Medomics SARS-CoV-2 Antigen Rapid Test (Nasal Swab) is intended to be used by laypersons as a self-test for home and workplace (in offices, for sporting events, airports, schools, etc.).